Page 415 - Binder2

Zea’s Model: Biologic Intelligence at Scale

Zea is among a new generation of biotech companies
treating AI not as a tool, but as the core operating system
for biologic development.

Their platform integrates:

• Gene-to-plant optimization algorithms,
streamlining design cycles.
• Cloud-based growth protocols, allowing
distributed partners to produce consistent biologics
from shared digital instructions.
• Patient-level feedback integration, creating a
closed loop between biology and response.

Each plant grown.
Each dose taken.
Each outcome logged.

All of it feeds back into the system—making the next
iteration smarter.

Zea’s model is self-improving medicine, where data isn’t
just for dashboards—it drives better biologics.

Risks and Responsibilities

Of course, power comes with risk. And AI—especially in
healthcare—can easily reproduce the same injustices we
aim to eliminate.

• Who owns the models that power production?

413